Michel M, Michel-Reher M, Hein P
Cells. 2020; 9(9).
PMID: 32825009
PMC: 7564766.
DOI: 10.3390/cells9091923.
Gubert C, Andrejew R, Leite C, Moritz C, Scholl J, Figueiro F
Mol Neurobiol. 2019; 57(3):1347-1360.
PMID: 31729632
DOI: 10.1007/s12035-019-01817-0.
Odagaki Y, Kinoshita M, Ota T, Meana J, Callado L, Matsuoka I
Purinergic Signal. 2018; 14(2):177-190.
PMID: 29492786
PMC: 5940630.
DOI: 10.1007/s11302-018-9603-x.
Sullivan L, Chavera T, Jamshidi R, Berg K, Clarke W
J Pharmacol Exp Ther. 2016; 359(3):411-419.
PMID: 27660244
PMC: 5118646.
DOI: 10.1124/jpet.116.232835.
Khan A, Li D, Ibrahim S, Smyth E, Woulfe D
Mol Pharmacol. 2014; 86(1):1-11.
PMID: 24723492
PMC: 4054002.
DOI: 10.1124/mol.114.091595.
The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified.
Moverare-Skrtic S, Borjesson A, Farman H, Sjogren K, Windahl S, Lagerquist M
Proc Natl Acad Sci U S A. 2014; 111(3):1180-5.
PMID: 24395795
PMC: 3903248.
DOI: 10.1073/pnas.1322910111.
Loss of constitutive activity is correlated with increased thermostability of the human adenosine A2A receptor.
Bertheleme N, Singh S, Dowell S, Hubbard J, Byrne B
Br J Pharmacol. 2013; 169(5):988-98.
PMID: 23489072
PMC: 3696323.
DOI: 10.1111/bph.12165.
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
Kargl J, Balenga N, Parzmair G, Brown A, Heinemann A, Waldhoer M
J Biol Chem. 2012; 287(53):44234-48.
PMID: 23161546
PMC: 3531739.
DOI: 10.1074/jbc.M112.364109.
Mahoganoid and mahogany mutations rectify the obesity of the yellow mouse by effects on endosomal traffic of MC4R protein.
Overton J, Leibel R
J Biol Chem. 2011; 286(21):18914-29.
PMID: 21460229
PMC: 3099707.
DOI: 10.1074/jbc.M111.224592.
Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.
Tao Y
Pharmacol Ther. 2008; 120(2):129-48.
PMID: 18768149
PMC: 2668812.
DOI: 10.1016/j.pharmthera.2008.07.005.
The temporal hormesis of drug therapies.
Dudekula N, Arora V, Callaerts-Vegh Z, Bond R
Dose Response. 2008; 3(3):414-24.
PMID: 18648614
PMC: 2475944.
DOI: 10.2203/dose-response.003.03.009.
Heterotrimeric g proteins: insights into the neurobiology of mood disorders.
Gonzalez-Maeso J, Meana J
Curr Neuropharmacol. 2008; 4(2):127-38.
PMID: 18615130
PMC: 2430671.
DOI: 10.2174/157015906776359586.
Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys.
Li J, McMahon L, France C
Psychopharmacology (Berl). 2007; 195(4):479-86.
PMID: 17874317
DOI: 10.1007/s00213-007-0914-9.
Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.
Zhang H, Shi Y, Woods J, Watson S, Ko M
Eur J Pharmacol. 2007; 570(1-3):89-96.
PMID: 17601558
PMC: 2031926.
DOI: 10.1016/j.ejphar.2007.05.045.
Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein.
Boulware M, Weick J, Becklund B, Kuo S, Groth R, Mermelstein P
J Neurosci. 2005; 25(20):5066-78.
PMID: 15901789
PMC: 6724851.
DOI: 10.1523/JNEUROSCI.1427-05.2005.
Protean agonism at histamine H3 receptors in vitro and in vivo.
Gbahou F, Rouleau A, Morisset S, Parmentier R, Crochet S, Lin J
Proc Natl Acad Sci U S A. 2003; 100(19):11086-91.
PMID: 12960366
PMC: 196931.
DOI: 10.1073/pnas.1932276100.
Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery.
Callaerts-Vegh Z, Evans K, Shipley G, Davies P, Cuba D, Gurji H
Br J Pharmacol. 2003; 138(8):1505-16.
PMID: 12721106
PMC: 1573808.
DOI: 10.1038/sj.bjp.0705205.
Regulated and constitutive activation of specific signalling pathways by the human S1P5 receptor.
Niedernberg A, Blaukat A, Schoneberg T, Kostenis E
Br J Pharmacol. 2003; 138(3):481-93.
PMID: 12569073
PMC: 1573682.
DOI: 10.1038/sj.bjp.0705055.
Alpha-1 adrenoceptor up-regulation induced by prazosin but not KMD-3213 or reserpine in rats.
Zhang L, Taniguchi T, Tanaka T, Shinozuka K, Kunitomo M, Nishiyama M
Br J Pharmacol. 2002; 135(7):1757-64.
PMID: 11934817
PMC: 1573304.
DOI: 10.1038/sj.bjp.0704639.
Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.
Rouleau A, Ligneau X, Tardivel-Lacombe J, Morisset S, Gbahou F, Schwartz J
Br J Pharmacol. 2002; 135(2):383-92.
PMID: 11815373
PMC: 1573152.
DOI: 10.1038/sj.bjp.0704490.
